Funding profile · Consumer diagnostics

Instalab

A pre-seed, YC-backed testing concierge with a reported $500,000 raised and no SEC filing to confirm it. Here is what the trackers say, and what the public record does not show.

$500KTotal raised, per CB Insights, PitchBook and Startup Intros
0Form D filings found on SEC EDGAR under the Instalab name
2Named investors: Y Combinator and Liquid 2 Ventures
11Employees reported by Tracxn and PitchBook (2026)

Data as of September 25, 2026. Company-reported and aggregator-reported figures are labeled.

Rounds at a glance

When Round Amount Investors Source
Jan 2022 Accelerator Not disclosed Y Combinator, Winter 2022 batch YC data
Undated Seed $500,000 total, no round-level breakdown given Y Combinator, Liquid 2 Ventures Aggregator data

What the filings show

Nothing. A search of SEC EDGAR’s company database for “Instalab” under any form type returned no results, and a full text search across EDGAR’s indexed filings for the word “Instalab” also returned zero hits, as of September 25, 2026. No Form D, amended or original, has been filed under that name. This matches the records already compiled for this profile: no Form D and no EDGAR mentions of the company in any filing by another entity.

Reading the filings, or the lack of them

  1. The $500,000 figure has no primary source.CB Insights, PitchBook and Startup Intros all independently report $500,000 raised from Y Combinator and Liquid 2 Ventures, but each is a third-party data aggregator, not a filing or a company statement found in this research. PitchBook labels the deal type “Seed,” separate from the accelerator line item, but gives no date or amount for it.
  2. A missing Form D is not unusual, but it is notable here.Companies that raise small rounds through SAFEs, convertible notes, or an exemption other than Regulation D can legitimately avoid filing a Form D. Y Combinator’s standard SAFE investment, and small angel rounds structured the same way, often fall under this pattern. CB Insights independently labeled the round a “Convertible Note,” consistent with a SAFE-style instrument rather than a priced equity round that would typically trigger a Form D.
  3. The founding year itself is contested.Y Combinator, the company, and this profile’s own intake record all list 2022. PitchBook lists 2021. No filing resolves which is correct, and the gap is small enough that it could reflect an incorporation date versus a launch date rather than an error.
  4. Headcount estimates diverge.Tracxn and PitchBook both report 11 employees as of 2026. Startup Intros, drawing on different signals, describes the company as having no reported employees in the same window. Neither figure is a filing; both are inferred from public profiles such as LinkedIn.
  5. No later round has been reported.No source found in this research describes a raise after the initial YC and Liquid 2 Ventures investment, and no press release, blog post or aggregator profile mentions a Series A or a named lead for a subsequent round.

Commercial signals

Signal Detail Source type
Distribution National at-home phlebotomy partnership with Getlabs, announced April 23, 2024. Company and partner release
Footprint Company site lists 4,080-plus partner labs and imaging centers across all 50 states plus DC, including 312 in New York. Company-stated
Catalog More than 600 lab tests and imaging studies listed for direct order, no referral required. Company-stated
Pricing A third-party aggregator lists an Instalab+ membership starting at $42 a month and a standalone 60-plus biomarker panel at $299; current site pricing was not independently confirmed at time of research. Aggregator-reported
Federal grants or FDA activity None found under the Instalab name in FDA 510(k), FDA PMA, NIH RePORTER or NSF award databases. Public record

What to watch

  • Any Form D that would finally put a filed date and amount behind the reported $500,000.
  • Whether the company raises a priced round, which would be more likely to generate a filing than a SAFE would.
  • Resolution of the 2021 versus 2022 founding date across trackers.
  • Confirmation, from a source other than an aggregator, of current membership and test pricing.

The Instalab story on Healthcare DiscoveryHealthcare Discovery

Related companies

  • NimbleRx: Shared investor: Liquid 2. Nimble began as a licensed dispensing pharmacy with its own stores, shut them in early 2019, and rebuilt itself as the software layer sold to the independent pharmacies
  • Clara: Shared investor: Liquid 2. An AI powered primary care practice built by the founders who scaled Circle Medical to nine figures in revenue
  • Scanbase: Shared investor: Liquid 2. An API that turns a phone photo of a rapid diagnostic test into a result, sold to the companies that make and ship the tests
  • H1: Shared investor: Liquid 2. A New York company that keeps a profile of roughly every doctor on earth and sells it to pharma, health insurers and now AI developers

Sources

  1. Public recordSEC EDGAR company search for “Instalab,” all form typesSEC EDGAR · searched Sep 25, 2026, zero results
  2. Public recordSEC EDGAR full text search for “Instalab”SEC EDGAR · searched Sep 25, 2026, zero results
  3. IndependentInstalab company profile, funding total, investors, Convertible Note labelCB Insights · snapshot Apr 23, 2024
  4. IndependentInstalab 2026 Company Profile, founded year, deal types, investors, employee countPitchBook · snapshot Jul 31, 2026
  5. IndependentInstalab 2026 Company Profile & Competitors, unfunded status, employee countTracxn · snapshot Apr 25, 2024 and Aug 2026
  6. IndependentInstalab: Funding, Team & InvestorsStartup Intros · snapshot Jul 13, 2026
  7. IndependentInstalab Funding, Complete Analysis, pricing figuresExtruct AI · snapshot Mar 26, 2022
  8. IndependentInstalab company page, Batch W22, founders listedY Combinator · accessed Sep 2026
  9. Company and partnerGetlabs and Instalab strategic partnership announcementPRNewswire, republished by CB Insights · Apr 23, 2024
  10. CompanyLab & Imaging Locations pageinstalab.com/locations · accessed Sep 2026
  11. Public recordFDA 510(k), FDA PMA, NIH RePORTER and NSF award database searches for “Instalab”Compiled in company records, zero results

Compiled from SEC and other public records and published reports as of September 25, 2026. Form D notices report offerings under Regulation D; amounts reflect the filing date. Healthcare Venture Capital Fund holds no position in Instalab. This page is not an offer to sell or a recommendation to buy any security.